Krystal Biotech, Inc. KRYS 深 沪
等待开盘 03-31 09:30:00 美东时间
246.94
+1.550
+0.63%
华盛通- 最 高249.46
- 今 开247.58
- 成交量 41.85万股
- 最 低 242.48
- 昨 收 245.39
- 总市值 72.19亿
- 52周最高 298.3025
- 市盈率 静 36.11
- 换手率 1.43%
- 52周最低 122.80
- 委 比 42.13%
- 总股本 2923.22万
- 历史最高 298.3025
- 量 比 1.54
- 振 幅 2.84%
- 历史最低 8.03
- 每 手 1
- 风险率 51.29%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Wolfe Research Initiates Coverage On Krystal Biotech with Peer Perform Rating
Wolfe Research analyst Kalpit Patel initiates coverage on Krystal Biotech (NASDAQ:KRYS) with a Peer Perform rating.
03-27 19:55
美股大行评级 | 大摩将应用材料目标价升至432美元；潜在涨幅200.0%！维尔生物科技获巴克莱升目标价至30美元，维持"超配"评级
今日重点评级关注：巴克莱：维持Vir Biotechnology"超配"评级，目标价从26美元升至30美元；巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从10美元升至11美元
02-26 09:30
美股大行评级 | 潜在涨幅216.49%！杰富瑞上调BioAge Labs目标价至62美元，评级升至"买入"
今日重点评级关注：杰富瑞：上调BioAge Labs评级至"买入"，目标价从9美元升至62美元；RBC Capital：维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级，目标价从21美元升至22美元
02-19 16:21
Citigroup Maintains Buy on Krystal Biotech, Raises Price Target to $371
Citigroup analyst Yigal Nochomovitz maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from $336 to $371.
02-19 01:59
Expert Outlook: Krystal Biotech Through The Eyes Of 9 Analysts
Ratings for Krystal Biotech (NASDAQ:KRYS) were provided by 9 analysts in the pa...
02-18 21:01
财报速睇 | Krystal Biotech, Inc. 2025财年Q4营收1.07亿美元，同比增长17.5%；归母净利润0.51亿美元，同比增长13.0%
华盛资讯2月18日讯，Krystal Biotech, Inc.公布2025财年Q4业绩，公司Q4营收1.07亿美元，同比增长17.5%，归母净利润0.51亿美元，同比增长13.0%。
02-18 02:45
Krystal Biotech shares are trading higher after the company announced better-than-expected Q4 financial results.
Krystal Biotech shares are trading higher after the company announced better-th...
02-18 02:09
Krystal Biotech: Q4 Earnings Insights
The earnings results for Krystal Biotech (NASDAQ:KRYS) for Q4 were made public ...
02-17 20:02
Krystal Biotech Q4 EPS $1.70 Beats $1.39 Estimate, Sales $107.105M Beat $105.338M Estimate
Krystal Biotech (NASDAQ:KRYS) reported quarterly earnings of $1.70 per share which beat the analyst consensus estimate of $1.39 by 22.21 percent. This is a 11.84 percent increase over earnings of $1.52 per share from the
02-17 20:01
Earnings Scheduled For February 17, 2026
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likel...
02-17 19:11
